Brief: Hofseth Biocare Q3 EBITDA loss widens to NOK 41.2 mln

Hofseth Biocare ASA

18/11/2016 06:34

Nov 18(Reuters) - Hofseth Biocare  HOFBC.OL : 
    * Reported on Thursday Q3 operating revenues of 3.6 million Norwegian crowns 
($420,000) versus 16.6 million crowns year ago 
    * Q3 EBITDA loss 41.2 million crowns versus loss 11.5 million crowns 
    * Q3 operating expenses amounted to 49.2 million crowns (32.3 million crowns 
year ago), including inventory write-offs of 25.9 million crowns 
 
     
 Source text for Eikon:  urn:newsml:reuters.com:*:nGNE7x1Fts 
     
 Further company coverage:  HOFBC.OL   
    
 
 
 
($1 = 8.5721 Norwegian crowns) 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))